Tokyo Electric Power Company Holdings (TEPCO) will begin its 16th release of treated radioactive water from the Fukushima ...

Alpha Nuclide's Research & Manufacturing Capabilities to Unlock Access to China Market, Targeting Clinical Trials for NY-703 in HCC in 2026 "We are excited to partner with Alpha Nuclide, a leader in ...

£5 million investment in King's biotech spin-out to identify and target therapy-resistant cancers. King's spin-out company Nuclide Therapeutics (NTx) has successfully closed a £5 million investment ...

Headshots of Nuclide Therapeutics cofounders Tim Witney (left) and Muhammet Tanc (right) standing outside. Nuclide Therapeutics cofounders Tim Witney (left) and Muhammet Tanc (right). Credit: Nuclide ...

Under the sponsorship of the U.S. Nuclear Regulatory Commission (NRC), the SCALE team recently implemented an enhancement to SCALE’s fast depletion modeling sequence, ORIGAMI, that enables users to ...

- Alliance spans the full antibody drugs (mAbs/BsAbs), ADCs, fusion proteins, and other bioconjugates development and production lifecycle from bench to bedside and advances commercialization ...

James is a published author with multiple pop-history and science books to his name. He specializes in history, space, strange science, and anything out of the ordinary.View full profile James is a ...

Anaplastic thyroid cancer (ATC) is a rare but aggressive form of thyroid cancer, accounting for nearly 50% of thyroid cancer-related deaths. Given its poor prognosis, the identification of new ...